In the aftermath of an important decision by the Supreme Court of the United States, the first impressions on the significance of the Mayo Collaborative Services v. Prometheus Laboratories, Inc. over the software patents debate in the United States. 
Supreme Court cases are decided by a majority of nine justices, and it is common for the ideologically diverse Court to issue one or more dissenting or concurring opinions in a case. This can sometimes leave doubt as to a holding's future significance. However, Justice Breyer's opinion in Mayo was joined by all the justices. This unanimity on what many viewed as a difficult question makes the decision a particularly strong precedent worth analyzing.
The Mayo case concerned the validity of patents of Prometheus relating to diagnostic testing for autoimmune diseases such as Crohn's disease and ulcerative colitis. The patents set forth levels of metabolites in the bloodstream that would indicate whether a particular drug dosage should be increased or decreased.
The Court began by noting that 35 U.S.C. Section 101 sets forth a broad area of patent eligibility, but that there is a judicially created exception that makes "laws of nature, natural phenomena, and abstract ideas" ineligible for patenting. The Court ultimately concluded that the Prometheus patent fell within the laws-of-nature exception.
The Court's interpretation of this exception is significant. The Court characterized the ways in which a drug is metabolized in the body as "entirely natural processes," and found that patents describing such processes "set[] forth a natural law." Although a patent may be granted for a process that applies a law of nature, this is possible only when the process involves something more than "well-understood, routine, conventional activity."
The connection between the biological processes at issue in Mayo and software patents is clear from the Court's reliance on three of its earlier cases that involved software -Diehr, Flook, and Benson. According to Mayo, these cases concerned patents involving "processes that embodied the equivalent of natural laws." Diehr 3 concerned a process for transforming uncured rubber into cured, molded products using the Arrhenius equation. Although the Diehr process as a whole was patentable, the Court found that, by itself, "the basic mathematical equation, like a law of nature, was not patentable." In Flook, 4 the Court found a formula for computing an alarm limit as part of a process for catalytic conversion of hydrocarbons was a basic mathematical equation that, "like a law of nature," was not patentable.
The Benson 5 case involved a process for converting binary-coded decimal numerals into pure binary numbers on a general purpose computer. The Mayo opinion describes Benson as holding "that simply implementing a mathematical principle on a physical machine, namely a computer, was not a patentable application of that principle." The Court viewed this as tantamount to a "claim that just said 'apply the algorithm.'" These references and the analogy to laws of nature will be important in future software patent cases. It is also interesting to note the Court's application of the machine-or-transfer test of Bilski. 6 In response to the argument that the blood of the individual was transformed in the course of the test, the Court said that the machine-or-transformation test was only "an 'important and useful clue' to patentability" which did not "trump the 'law of nature' exclusion." In other words, the Bilski test, even if satisfied, does not allow patenting of laws of nature. The Mayo opinion indicates the same ought to be true for mathematical algorithms. In a future case, it may be argued, as some computer scientists hold, that software is nothing more or less than mathematical algorithms.
It also seems noteworthy that the Mayo Court outlined a balanced view of the patent system that took account of the risks it can pose for innovation. It wrote, "Patent protection is, after all, a twoedged sword. On the one hand, the promise of exclusive rights provides monetary incentives that lead to creation, invention, and discovery. On the other hand, that very exclusivity can impede the flow of information that might permit, indeed spur, invention, by, for example, raising the price of using the patented ideas once created, requiring potential users to conduct costly and timeconsuming searches of existing patents and pending patent applications, and requiring the negotiation of complex licensing arrangements." The Court also noted that monopolization of abstract intellectual concepts and other basic tools "through the grant of a patent might tend to impede innovation more than it would tend to promote it."
Conclusion
The stance of the Court on the patent system may not sound surprising to FOSS community members who are knowledgeable about the problems of software patents. But Americans are taught from an early age to venerate the patent system. Many end up with an unshakeable belief that it always fosters progress, and cannot conceive that it sometimes hinders innovation. In Mayo, all nine Justices recognized that the reality is more complicated. The Court may not be ready yet to take on the software patent problem, but its practical, empirical approach could be a harbinger of progress to come. 
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